Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3

Journal of Virology

Volumn 75, Issue 4, 2001, Pages 1990-1995

  Harouse, J M ^a   Gettie, A ^a   Eshetu, T ^a   Tan, R C H ^a   Bohm, R ^a   Blanchard, J ^a   Baskin, G ^a   Cheng Mayer, C ^a  

^a Aaron Diamond AIDS Research Centre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DISEASE COURSE; DRUG MECHANISM; DRUG SCREENING; HOST SUSCEPTIBILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MACACA; MONKEY DISEASE; MONONUCLEAR CELL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIMATE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CERVIX UTERI; FEMALE; HIV-1; HUMANS; MACACA MULATTA; MUCOUS MEMBRANE; RECEPTORS, CCR5; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA;

EID: 0035132287     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.4.1990-1995.2001     Document Type: Article

References (24)

1. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
2. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
3. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
4. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques
5. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
6. + T cells and AIDS in pig-tailed macaques
7. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
8. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
9. Utility of SHIV for testing HIV-1 vaccine candidates in macaques
10. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV)
11. Viral diseases
12. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR δ32
13. Mucosal transmission of simian immunodeficiency virus
14. In vivo replication rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques
15. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques
16. A simple method for estimating 50 percent endpoints
17. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys
18. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: Determinants of high virus loads and CD4 cell killing
19. In vivo adaptation of SHIV(SF162): Chimeric virus expressing a NSI, CCR5-specific envelope protein
20. HIV-1 infection in an individual homozygous for CCR5 delta 32: Seroco study group
21. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during course of human immunodeficiency virus infection
22. AIDS preclinical vaccine development: Biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates
23. Selective transmission of human immunodeficieney virus type-1 variants from mothers to infants
24. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission